Alibaba Health Information Technology (HKSE:00241) Debt-to-EBITDA : 0.09 (As of Sep. 2023)

View and export this data going back to 1972. Start your Free Trial

What is Alibaba Health Information Technology Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Alibaba Health Information Technology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was HK$42 Mil. Alibaba Health Information Technology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was HK$53 Mil. Alibaba Health Information Technology's annualized EBITDA for the quarter that ended in Sep. 2023 was HK$1,092 Mil. Alibaba Health Information Technology's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was 0.09.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Alibaba Health Information Technology's Debt-to-EBITDA or its related term are showing as below:

HKSE:00241' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -58.87 Med: -0.32 Max: 0.96
Current: 0.09

During the past 13 years, the highest Debt-to-EBITDA Ratio of Alibaba Health Information Technology was 0.96. The lowest was -58.87. And the median was -0.32.

HKSE:00241's Debt-to-EBITDA is ranked better than
92.64% of 421 companies
in the Healthcare Providers & Services industry
Industry Median: 2.6 vs HKSE:00241: 0.09

Alibaba Health Information Technology Debt-to-EBITDA Historical Data

The historical data trend for Alibaba Health Information Technology's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alibaba Health Information Technology Debt-to-EBITDA Chart

Alibaba Health Information Technology Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-EBITDA

Get a 7-Day Free Trial

-58.87

0.96

0.09

-0.72

0.13

Alibaba Health Information Technology Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-EBITDA	Get a 7-Day Free Trial															-0.17	3.77	0.21	0.10	0.09

Competitive Comparison of Alibaba Health Information Technology's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alibaba Health Information Technology's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's Debt-to-EBITDA falls into.

Alibaba Health Information Technology Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Alibaba Health Information Technology's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(42.641	+	45.971)	/	706.799
	=	0.13

Alibaba Health Information Technology's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(41.716	+	52.932)	/	1091.906
	=	0.09

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Sep. 2023) EBITDA data.

Alibaba Health Information Technology (HKSE:00241) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Alibaba Health Information Technology Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Alibaba Health Information Technology's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Alibaba Health Information Technology (HKSE:00241) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Alibaba Health Information Technology Ltd (HKSE:00241) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

ALBBY:USA ALBHF:USA TWY:Germany

Address

Guanghua Road, 65/F, CITIC Tower, Building 1, No.10, Jianwai Subdistrict, Chaoyang District, Beijing, CHN

Website

https://www.alihealth.cn

Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

Alibaba Health Information Technology (HKSE:00241) Headlines

No Headlines